This report describes a case of a Stanford Type B aortic dissection (originating distal to the left subclavian artery and extending to the aortic bifurcation and proximal left iliac artery) in a 31-year-old primigravid woman who was at 39 weeks gestation and had Marfan's syndrome. The dissection was managed conservatively. Caesarean section was performed under epidural anaesthesia with aggressive control of hypertension. Postoperatively, there was no extension of the dissection and no aneurysm formation. She was discharged from hospital two weeks after delivery and remained asymptomatic at six months. There are no plans for surgical intervention.
Marfan's syndrome is a connective tissue disorder 1 caused by mutation in a gene on chromosome 15 encoding fibrillin 2 . This is an important structural component of micofibrils, and the disorder manifests with ocular, cardiovascular and musculoskeletal abnormalities. Cardiovascular features include mitral valve prolapse and aortic dilatation. The latter may progress to aortic dissection, rupture or aortic regurgitation and is primarily responsible for the reduced life expectancy associated with Marfan's syndrome. The mean age of death is 32 years 3 . This report describes the anaesthetic management of caesarean section in a patient with Marfan's syndrome and aortic dissection. The prime aim of management was to control hypertension, reducing the risk of subsequent aortic rupture.
CASE HISTORY
A 31-year-old primigravida of height 176.5 cm had been diagnosed with Marfan's syndrome at the age of six years. At 12 years she had symptoms of myopia, pectus excavatum, scoliosis and moderate mitral valve prolapse. A transthoracic echocardiogram at 26 years of age showed an aortic root diameter of 41 mm (normal adult range 20-37 mm, mean 27 mm) and this had increased to 44 mm by 28 years of age.
At this time she underwent mitral valve replacement. A transoesophageal echocardiogram (TOE) at 30 years of age showed satisfactory mitral valve repair, with the aortic root diameter remaining at 44 mm. Her medication was metoprolol 100 mg bd to protect the aortic root from further dilatation or dissection.
The patient had previously undergone laparoscopic and laser surgery for endometriosis. She had antiphospholipid antibody syndrome and protein S deficiency. Low molecular weight heparin (enoxaparin sodium, Clexane, Rhone-Poulenc Rorer Australia) 40 mg daily and aspirin were used to facilitate conception following numerous in vitro fertilization treatments. A spontaneous vaginal delivery with early epidural analgesia was planned. Systolic blood pressure throughout pregnancy was kept within the 110 to 125 mmHg range with metoprolol. A transthoracic echocardiogram at 12 weeks showed an aortic root diameter of 44 mm. Enoxaparin was stopped at 27 weeks gestation, as is usual in this institution, in order that no anticoagulant is being given at the time of delivery of a potentially viable fetus and also because anticardiolipin antibody titres were low. Aspirin was ceased at 32 weeks.
At 39 weeks gestation, she presented with a twohour history of severe chest pain radiating to the back, having experienced a similar episode one week earlier. Aortic dissection was suspected. Continuous external fetal monitoring was commenced using cardiotocography. This showed a fetal heart rate (FHR) of 120 beats/minute with a normal pattern. Fetal movements were present. A CT scan was performed, revealing a Stanford Type B aortic dissection from the descending aorta immediately distal to the left subclavian artery, extending to the aortic bifurcation and proximal part of the left external iliac artery. Blood pressure at this time was 120/70 mmHg and heart rate 80 beats/minute. A glyceryl trinitrate (GTN) infusion was commenced and oral metoprolol was continued, aiming to maintain a systolic blood pressure of 100 to 110 mmHg. The FHR remained stable. A plan was made for caesarean section to be performed under epidural blockade once haemodynamic stability had been achieved.
Oral sodium citrate and ranitidine were given as premedication. On arrival in theatre, two 14 gauge intravenous cannulae were inserted and the right radial artery cannulated for continuous invasive blood pressure monitoring. Despite the GTN infusion (at 30 to 90 µg/min), hypertension was not controlled (160/70 mmHg). After an esmolol infusion (400 mg/h with four 30 mg boluses) and two 5 mg boluses of hydralazine, there was a gradual fall in blood pressure over 20 minutes to 110/50 mmHg. At this stage a lumbar epidural was inserted and sensory block to T4 achieved using 2 to 3 ml incremental boluses of 0.5% bupivacaine with 5 µg/ml fentanyl over 30 minutes (total dose 65 mg of bupivacaine and 65 µg of fentanyl). Left lateral tilt was employed. The FHR just prior to epidural insertion was 125 beats/minute and this remained stable during administration of bupivacaine. A peak in blood pressure to 150/70 mmHg occurred for 10 minutes from surgical incision until shortly after delivery. Maternal heart rate gradually increased from 70 beats/min on arrival in theatre to a peak of 100 beats/min after delivery. Two 1 mg boluses of atenolol were given, resulting in a steady decline in heart rate and blood pressure to 80 beats/min and 110/40 mmHg respectively, at the end of surgery. A live 3.68 kg male infant was delivered, with Apgar scores of 9 at 1 minute and 10 at 5 minutes. Intravenous oxytocin (10 IU) was administered to contract the uterus.
Postoperatively, the patient was transferred to the intensive care unit for 24 hours and on the next postoperative day she was weaned from esmolol. GTN was continued for eight days with direct blood pressure monitoring, again aiming for a systolic blood pressure between 100 and 105 mmHg. The dose was gradually increased to a maximum of 300 µg/min on the fifth postoperative day, before weaning. Oral lisinopril, nifedipine and a thiazide diuretic were added for persisting hypertension. Satisfactory analgesia was provided with a 0.125% bupivacaine and fentanyl (2 µg/ml) epidural infusion for five days. A CT scan seven days after delivery showed no change in the dissection and no aneurysm formation and she was discharged on the 14th postoperative day on her oral antihypertensive medication.
A TOE four months after delivery showed an aortic root diameter of 45 mm. Six months after delivery, the patient remained asymptomatic and required only metoprolol for control of hypertension. No plan has been made for surgery.
DISCUSSION
Reduced connective tissue strength in Marfan's syndrome is associated with histological changes of medial cystic necrosis. This may result in a transverse medial tear in the aortic wall, marking the start of an aortic dissection. The dissection channel, in common with dissection from other causes, lies in the outer half of the aortic media and is associated with a high frequency of rupture of the thin outer wall of the false channel 4 . Pregnancy itself has been associated with aortic dissection 5 . Causative factors are thought to include hypertension and increased blood volume. Oestrogen has been shown to inhibit collagen and elastin deposition in the aorta and progestogen accelerates deposition of non-collagenous proteins in the rat aorta 6 .
It has therefore generally been thought that pregnancy in women with Marfan's syndrome is associated with a high risk of life-threatening cardiovascular complications, although under-reporting of uneventful pregnancies may have enhanced this opinion. The fetus has a 50% chance of inheriting the abnormal gene.
Despite the concerns regarding aortic dissection in pregnant women with Marfan's syndrome, a retrospective analysis by Pyeritz of 105 pregnancies in 26 women with Marfan's syndrome concluded that where there was minimal cardiovascular involvement before pregnancy, it was unlikely that pregnancy would lead to serious acute cardiovascular problems 7 . Based on reported cases, he concluded that in those patients with an aortic diameter of less than 40 mm, the risk of aortic dissection was small. In contrast, patients with aortic regurgitation, haemodynamically significant mitral valve dysfunction or an aortic root dilatation of more than 40 mm were at high risk of a life-threatening cardiovascular complication during or shortly after pregnancy.
A prospective uncontrolled study of 45 pregnancies in 21 patients with Marfan's syndrome identified aortic dissection in two cases 8 . One patient had aortic regurgitation and an aortic root diameter of 42 mm before pregnancy. The other had developed an aortic dissection that was repaired six months before conception. There was little or no change in aortic root diameter throughout pregnancy in most patients and it was concluded that women with Marfan's syndrome with minor cardiovascular involvement and an aortic diameter of less than 40 mm tolerated pregnancy well.
A more recent retrospective study of 91 pregnancies in 36 patients with Marfan's syndrome found four women who had aortic dissection and a further two who required aortic surgery for aortic root dilatation 9 . Of the four cases of aortic dissection, two occurred in women in whom Marfan's syndrome was not diagnosed until after the dissection. The other two cases had aortic root diameters of 40 and 42 mm at the time of dissection and both were normotensive. The authors concluded that the risk during pregnancy in all patients with Marfan's syndrome was considerable. Aortic root dilatation was not necessarily a predictor of aortic dissection, but the rate of change in aortic root diameter appeared to be an important predictor of risk even when measurement was less than 40 mm. Monthly TOE during pregnancy was recommended, with aggressive treatment of hypertension. Vaginal delivery with epidural anaesthesia was recommended for women with stable aortic measurements of less than 40 mm and elective caesarean section with epidural anaesthesia for those with aortic root changes during pregnancy or a diameter greater than 40 mm.
A case report by Rosenblum et al showed that serial echocardiographic evaluation in a patient with Marfan's syndrome and mitral prolapse failed to predict an aortic dissection during the 36th week of pregnancy. This complication occurred despite an aortic root diameter of only 36 mm at 13, 20 and 28 weeks gestation 10 .
The patient described in this report met the criteria for high risk of dissection because of her preconceptual aortic root diameter above 40 mm. Elective caesarean section under epidural anaesthesia may have been the delivery method of choice 9 . An aortic root diameter of 50 mm is accepted as the threshold above which elective surgery is undertaken in the symptom-free patient 11 . In this patient, no further echocardiograms were performed after the first trimester. Serial monthly TOEs would have provided information concerning further aortic dilatation. In retrospect, it appears unlikely that there was significant widening of the aorta, the diameter of which was only 1 mm wider at three months postpartum.
This patient was taking prophylactic metoprolol before and during pregnancy. A prospective randomized trial of non-pregnant patients with Marfan's syndrome using propranolol confirmed that beta-sympathetic blockers reduce aortic dilatation 12 . Their routine administration from at least the midtrimester has been recommended 8 . All beta blockers cross the placenta. However, there have been no reports of teratogenicity 13 . Retrospective studies and case reports suggest fetal side-effects of propranolol include fetal growth retardation, hypoglycaemia and respiratory depression, but this is not supported by randomized prospective studies. Neonatal bradycardia has been reported in association with atenolol and metoprolol, although no case required intervention. The fetal bradycardic response to stress appears to be parasympathetic and is not masked by beta blockade. Propranolol, but not beta 1 -selective drugs, may theoretically increase uterine activity by blocking the inhibitory effect of adrenaline on the myometrium. However, animal studies do not support increased uterine activity during beta blockade 13 .
Once aortic dissection had been suspected, a CT scan, rather than a TOE, was performed. Although TOE has been shown to be superior to the transthoracic approach in the diagnosis of aortic dilatation and dissection, it would not have shown the full extent of the dissection in this case. The right radial artery was cannulated, rather than the left, to reduce the possibility of error should the dissection have extended proximally and occluded the left subclavian artery.
A vigorous effort was made to maintain the systolic blood pressure in the 100 to 110 mmHg range perioperatively. Delivery by caesarean section avoided possible hypertensive responses to labour pain and a regional technique avoided the hypertensive response to intubation after induction of general anaesthesia. Rather than subarachnoid block, a controlled incremental epidural technique was chosen to avoid large falls in blood pressure. The concern was that vasopressor therapy to maintain placental perfusion may have caused rebound hypertension and increased the risk of aortic rupture. A central line was not inserted because it was considered unlikely to contribute significantly to the management of hypertension and because in an awake patient, discomfort during insertion may have caused hypertension. Intravenous access was good and all drugs intended for use were safe to be given peripherally. Ergometrine was avoided at delivery due to its possible hypertensive effect. Despite aggressive treatment, hypertension was still evident during the caesarean section. No change in FHR was observed following GTN, esmolol and hydralazine administration. GTN crosses the placenta, achieving fetal levels two to three orders of magnitude lower than in maternal venous plasma and it is rapidly metabolized. Maternal intravenous boluses of GTN 0.25 to 0.5 mg have not resulted in adverse fetal effects 14 . The effects of esmolol, which has a low lipid solubility compared to longer-acting beta blockers, have not been studied in detail during pregnancy. A small reduction in FHR in a pre-term fetus has been reported after maternal esmolol administration 15 , and severe fetal bradycardia described after maternal administration when the fetoplacental circulation was already compromised 16 . Intravenous hydralazine also crosses the placenta and has been associated with fetal distress and fetal arrhythmias 17 , but is widely used in the antepartum control of hypertension. Had a more potent hypotensive agent such as sodium nitroprusside been used, more effective control of blood pressure may have been achieved without the need for multiple agents. However, this approach increases the risk of hypotension and the potential for undesirable administration of vasoconstrictors.
Persistent post delivery hypertension may be caused by a "pseudo-coarctation" effect resulting from compression of the aortic lumen by the false channel and a reflex increase in renin secretion caused by relative renal hypoperfusion 18 . The epidural infusion was continued for an extended period postoperatively because hypertension was difficult to control and the benefit of prolonged analgesia was considered to outweigh the small risk of epidural abscess. On ceasing epidural analgesia on day 5, upper back pain occurred, resulting in further hypertension and increased GTN requirements. This was thought to be secondary to unmasking of residual pain from the aortic dissection. The patient remained apyrexial and the epidural site was inspected daily. In view of her previous mitral valve replacement, a course of intravenous vancomycin was given for perioperative prophylaxis against endocarditis. Non-steroidal antiinflammatory drugs were not used, in order to avoid the risk of bleeding in the presence of aortic dissection.
In conclusion, the management of caesarean section under epidural anaesthesia in a patient with Marfan's syndrome and an extensive aortic dissection is described. Multiple drugs and methods were required to control perioperative hypertension. The patient remained asymptomatic six months after delivery.
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